Phase II clinical trial of chemotherapy-naive patients≥ 70 years of age treated with erlotinib for advanced non–small-cell lung cancer
DM Jackman, BY Yeap, NI Lindeman… - Journal of Clinical …, 2007 - ascopubs.org
Purpose This is a phase II, multicenter, open-label study of chemotherapy-naïve patients
with non–small-cell lung cancer (NSCLC) and age≥ 70 years who were treated with …
with non–small-cell lung cancer (NSCLC) and age≥ 70 years who were treated with …
Phase II clinical trial of chemotherapy-naive patients> or= 70 years of age treated with erlotinib for advanced non-small-cell lung cancer
DM Jackman, BY Yeap, NI Lindeman… - Journal of clinical …, 2007 - pubmed.ncbi.nlm.nih.gov
Purpose This is a phase II, multicenter, open-label study of chemotherapy-naïve patients
with non-small-cell lung cancer (NSCLC) and age> or= 70 years who were treated with …
with non-small-cell lung cancer (NSCLC) and age> or= 70 years who were treated with …
[PDF][PDF] Phase II Clinical Trial of Chemotherapy-Naıve Patients 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer
DM Jackman, BY Yeap, NI Lindeman, P Fidias… - J Clin …, 2007 - scholar.archive.org
Purpose This is a phase II, multicenter, open-label study of chemotherapy-naıve patients
with non–smallcell lung cancer (NSCLC) and age 70 years who were treated with erlotinib …
with non–smallcell lung cancer (NSCLC) and age 70 years who were treated with erlotinib …
[PDF][PDF] Phase II Clinical Trial of Chemotherapy-Naıve Patients 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer
DM Jackman, BY Yeap, NI Lindeman, P Fidias… - J Clin Oncol, 2007 - grg-bs.it
Purpose This is a phase II, multicenter, open-label study of chemotherapy-naıve patients
with non–smallcell lung cancer (NSCLC) and age 70 years who were treated with erlotinib …
with non–smallcell lung cancer (NSCLC) and age 70 years who were treated with erlotinib …
Phase II clinical trial of chemotherapy-naive patients> or= 70 years of age treated with erlotinib for advanced non-small-cell lung cancer.
DM Jackman, BY Yeap, NI Lindeman… - Journal of Clinical …, 2007 - europepmc.org
Purpose This is a phase II, multicenter, open-label study of chemotherapy-naïve patients
with non-small-cell lung cancer (NSCLC) and age> or= 70 years who were treated with …
with non-small-cell lung cancer (NSCLC) and age> or= 70 years who were treated with …
Phase II Clinical Trial of Chemotherapy-Naïve Patients≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer
DM Jackman, BY Yeap, NI Lindeman, P Fidias… - Journal of Clinical …, 2007 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> This is a phase II, multicenter, open-
label study of chemotherapy-naïve patients with non–small-cell lung cancer (NSCLC) and …
label study of chemotherapy-naïve patients with non–small-cell lung cancer (NSCLC) and …
[引用][C] Phase ii clinical trial of chemotherapy-naive patients≥ 70 years of age treated with erlotinib for advanced non-small-cell lung cancer
DM JACKMAN, BY YEAP, B FREIDLIN… - Journal of clinical …, 2007 - pascal-francis.inist.fr
Phase ii clinical trial of chemotherapy-naive patients ≥ 70 years of age treated with erlotinib
for advanced non-small-cell lung cancer CNRS Inist Pascal-Francis CNRS Pascal and …
for advanced non-small-cell lung cancer CNRS Inist Pascal-Francis CNRS Pascal and …